List of Excipients in API lopinavir and ritonavir
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lopinavir and ritonavir
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| AbbVie Inc | KALETRA | lopinavir and ritonavir | 0074-0522 | COPOVIDONE K25-31 | |
| AbbVie Inc | KALETRA | lopinavir and ritonavir | 0074-0522 | FERRIC OXIDE YELLOW | |
| AbbVie Inc | KALETRA | lopinavir and ritonavir | 0074-0522 | POLYETHYLENE GLYCOL 3350 | |
| AbbVie Inc | KALETRA | lopinavir and ritonavir | 0074-0522 | POLYVINYL ALCOHOL | |
| AbbVie Inc | KALETRA | lopinavir and ritonavir | 0074-0522 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing lopinavir and ritonavir
Detailed excipient profiles for lopinavir and ritonavir
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
lopinavir and ritonavir drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | lopinavir and ritonavir | 33342-163 |
| >Company | >Ingredient | >NDC |
lopinavir and ritonavir drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: COLLOIDAL SILICON DIOXIDE
lopinavir and ritonavir drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | lopinavir and ritonavir | 21695-362 |
| Dispensing Solutions Inc | lopinavir and ritonavir | 66336-624 |
| Dispensing Solutions Inc | lopinavir and ritonavir | 68258-1972 |
| >Company | >Ingredient | >NDC |
lopinavir and ritonavir drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: COPOVIDONE
lopinavir and ritonavir drug variants containing COPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | lopinavir and ritonavir | 21695-362 |
| Macleods Pharmaceuticals Limited | lopinavir and ritonavir | 33342-163 |
| Laurus Labs Limited | lopinavir and ritonavir | 42385-933 |
| NuCare PharmaceuticalsInc | lopinavir and ritonavir | 68071-2949 |
| >Company | >Ingredient | >NDC |
lopinavir and ritonavir drug variants not containing COPOVIDONE
Excipient focus: COPOVIDONE K25-31
lopinavir and ritonavir drug variants containing COPOVIDONE K25-31
lopinavir and ritonavir drug variants not containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | lopinavir and ritonavir | 21695-362 |
| Macleods Pharmaceuticals Limited | lopinavir and ritonavir | 33342-163 |
| Laurus Labs Limited | lopinavir and ritonavir | 42385-933 |
| NuCare PharmaceuticalsInc | lopinavir and ritonavir | 68071-2949 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
lopinavir and ritonavir drug variants containing FERRIC OXIDE YELLOW
lopinavir and ritonavir drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
lopinavir and ritonavir drug variants containing HYDROXYPROPYL CELLULOSE
lopinavir and ritonavir drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | lopinavir and ritonavir | 0074-0522 |
| Macleods Pharmaceuticals Limited | lopinavir and ritonavir | 33342-163 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
lopinavir and ritonavir drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| PD-Rx Pharmaceuticals Inc | lopinavir and ritonavir | 55289-947 |
| NuCare PharmaceuticalsInc | lopinavir and ritonavir | 68071-2348 |
| REMEDYREPACK INC | lopinavir and ritonavir | 70518-0091 |
| >Company | >Ingredient | >NDC |
lopinavir and ritonavir drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
lopinavir and ritonavir drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | lopinavir and ritonavir | 31722-556 |
| Laurus Labs Limited | lopinavir and ritonavir | 42385-933 |
| NuCare PharmaceuticalsInc | lopinavir and ritonavir | 68071-2949 |
| >Company | >Ingredient | >NDC |
lopinavir and ritonavir drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
lopinavir and ritonavir drug variants containing HYPROMELLOSES
lopinavir and ritonavir drug variants not containing HYPROMELLOSES
Excipient focus: POLYETHYLENE GLYCOL 3350
lopinavir and ritonavir drug variants containing POLYETHYLENE GLYCOL 3350
lopinavir and ritonavir drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
lopinavir and ritonavir drug variants containing POLYETHYLENE GLYCOL 400
lopinavir and ritonavir drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | lopinavir and ritonavir | 0074-0522 |
| Macleods Pharmaceuticals Limited | lopinavir and ritonavir | 33342-163 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
lopinavir and ritonavir drug variants containing POLYSORBATE 80
lopinavir and ritonavir drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | lopinavir and ritonavir | 0074-0522 |
| Macleods Pharmaceuticals Limited | lopinavir and ritonavir | 33342-163 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
lopinavir and ritonavir drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| AbbVie Inc | lopinavir and ritonavir | 0074-0522 |
| >Company | >Ingredient | >NDC |
lopinavir and ritonavir drug variants not containing POLYVINYL ALCOHOL
Excipient focus: SILICON DIOXIDE
lopinavir and ritonavir drug variants containing SILICON DIOXIDE
lopinavir and ritonavir drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | lopinavir and ritonavir | 21695-362 |
| Dispensing Solutions Inc | lopinavir and ritonavir | 66336-624 |
| Dispensing Solutions Inc | lopinavir and ritonavir | 68258-1972 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
lopinavir and ritonavir drug variants containing SODIUM STEARYL FUMARATE
lopinavir and ritonavir drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOLAURATE
lopinavir and ritonavir drug variants containing SORBITAN MONOLAURATE
lopinavir and ritonavir drug variants not containing SORBITAN MONOLAURATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
lopinavir and ritonavir drug variants containing TALC
lopinavir and ritonavir drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
lopinavir and ritonavir drug variants containing TITANIUM DIOXIDE
lopinavir and ritonavir drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
